Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drugging K-RasG12C through covalent inhibitors: Mission possible?
Duan Ni, Xinyi Li, Xinheng He, et al.
Pharmacology & Therapeutics (2019) Vol. 202, pp. 1-17
Closed Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

RAS: Striking at the Core of the Oncogenic Circuitry
Ryan C. Gimple, Xiuxing Wang
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 145
Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
Xin Xie, Tingting Yu, Xiang Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 137
The path to the clinic: a comprehensive review on direct KRASG12C inhibitors
Albert K. Kwan, Gary A. Piazza, Adam B. Keeton, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 128
Discovery of cryptic allosteric sites using reversed allosteric communication by a combined computational and experimental strategy
Duan Ni, Jiacheng Wei, Xinheng He, et al.
Chemical Science (2020) Vol. 12, Iss. 1, pp. 464-476
Open Access | Times Cited: 107
Emergence of allosteric drug-resistance mutations: new challenges for allosteric drug discovery
Shaoyong Lu, Yuran Qiu, Duan Ni, et al.
Drug Discovery Today (2019) Vol. 25, Iss. 1, pp. 177-184
Closed Access | Times Cited: 79
Mechanism of allosteric activation of SIRT6 revealed by the action of rationally designed activators
Shaoyong Lu, Ying-Yi Chen, Jiacheng Wei, et al.
Acta Pharmaceutica Sinica B (2020) Vol. 11, Iss. 5, pp. 1355-1361
Open Access | Times Cited: 73
Mechanistic insights into the effect of phosphorylation on Ras conformational dynamics and its interactions with cell signaling proteins
Yuanhao Wang, Dong Ji, Chaoyu Lei, et al.
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 1184-1199
Open Access | Times Cited: 60
Promoting anti-tumor immunity by targeting TMUB1 to modulate PD-L1 polyubiquitination and glycosylation
Chengyu Shi, Ying Wang, Minjie Wu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 40
Ferroptosis: Promising approach for cancer and cancer immunotherapy
Shuyue Zheng, Xin‐Yuan Guan
Cancer Letters (2023) Vol. 561, pp. 216152-216152
Closed Access | Times Cited: 36
Simultaneous Covalent Modification of K-Ras(G12D) and K-Ras(G12C) with Tunable Oxirane Electrophiles
Zhongtang Yu, Xiaoqiang He, R. WANG, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 37, pp. 20403-20411
Closed Access | Times Cited: 24
Outcomes following KRASG12C inhibitor treatment in patients with KRASG12C-mutated solid tumors: A systematic review and meta-analysis
Qian Chen, Weihao Lin, Xiao-xiang Zhou, et al.
Pharmacological Research (2024) Vol. 200, pp. 107060-107060
Open Access | Times Cited: 7
Unraveling allosteric landscapes of allosterome with ASD
Xinyi Liu, Shaoyong Lu, Kun Song, et al.
Nucleic Acids Research (2019)
Open Access | Times Cited: 60
Discovery of Novel PDEδ Degraders for the Treatment of KRAS Mutant Colorectal Cancer
Junfei Cheng, Yu Li, Xu Wang, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 14, pp. 7892-7905
Closed Access | Times Cited: 55
The Ins and Outs of RAS Effector Complexes
Christina Kiel, David Matallanas, Walter Kölch
Biomolecules (2021) Vol. 11, Iss. 2, pp. 236-236
Open Access | Times Cited: 49
Along the allostery stream: Recent advances in computational methods for allosteric drug discovery
Duan Ni, Zong‐Tao Chai, Ying Wang, et al.
Wiley Interdisciplinary Reviews Computational Molecular Science (2021) Vol. 12, Iss. 4
Closed Access | Times Cited: 49
Untangling Dual-Targeting Therapeutic Mechanism of Epidermal Growth Factor Receptor (EGFR) Based on Reversed Allosteric Communication
Yuran Qiu, Xiaolan Yin, Xinyi Li, et al.
Pharmaceutics (2021) Vol. 13, Iss. 5, pp. 747-747
Open Access | Times Cited: 46
AlloReverse: multiscale understanding among hierarchical allosteric regulations
Jinyin Zha, Qian Li, Xinyi Liu, et al.
Nucleic Acids Research (2023) Vol. 51, Iss. W1, pp. W33-W38
Open Access | Times Cited: 18
Comparative effects of oncogenic mutations G12C, G12V, G13D, and Q61H on local conformations and dynamics of K-Ras
Sezen Vatansever, Burak Erman, Zeynep H. Gümüş
Computational and Structural Biotechnology Journal (2020) Vol. 18, pp. 1000-1011
Open Access | Times Cited: 47
Drug design targeting active posttranslational modification protein isoforms
Fanwang Meng, Zhongjie Liang, Kehao Zhao, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 3, pp. 1701-1750
Closed Access | Times Cited: 42
40 Years of RAS—A Historic Overview
Alberto Fernández‐Medarde, Javier De Las Rivas, Eugenio Santos
Genes (2021) Vol. 12, Iss. 5, pp. 681-681
Open Access | Times Cited: 38
Harnessing Reversed Allosteric Communication: A Novel Strategy for Allosteric Drug Discovery
Jigang Fan, Yaqin Liu, Ren Kong, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 24, pp. 17728-17743
Closed Access | Times Cited: 34
Markov State Models and Molecular Dynamics Simulations Reveal the Conformational Transition of the Intrinsically Disordered Hypervariable Region of K-Ras4B to the Ordered Conformation
Hao Zhang, Duan Ni, Jigang Fan, et al.
Journal of Chemical Information and Modeling (2022) Vol. 62, Iss. 17, pp. 4222-4231
Closed Access | Times Cited: 25
Characterization With KRAS Mutant Is a Critical Determinant in Immunotherapy and Other Multiple Therapies for Non-Small Cell Lung Cancer
Mo Shen, Rongbin Qi, Justin Ren, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 22
Insight into the mechanism of allosteric activation of PI3Kα by oncoprotein K-Ras4B
Xinyi Li, Jinyuan Dai, Duan Ni, et al.
International Journal of Biological Macromolecules (2019) Vol. 144, pp. 643-655
Closed Access | Times Cited: 36
Multiple Strategies to Develop Small Molecular KRAS Directly Bound Inhibitors
Xile Zhou, Yang Ji, Jinming Zhou
Molecules (2023) Vol. 28, Iss. 8, pp. 3615-3615
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top